Concepedia

Publication | Open Access

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

DOIFull Paper Access

44

Citations

20

References

2016

Year

Sophie Piperno‐Neumann, Alhassane Diallo, Marie-Christine Étienne-Grimaldi, François‐Clément Bidard, Manuel Rodrigues, Corine Plancher, Pascale Mariani, Nathalie Cassoux, Didier Decaudin, Bernard Asselain,
The Oncologist

Abstract

In patients with MUM, a combination of bevacizumab plus temozolomide achieved a 6-month PFR of 23%.

References

YearCitations

Page 1